Drug and Medication Industry Market Research Reports in South Korea, June 2013

Company Report: Drug in South Korea for Year 2013

• Company report
• February 2013
• 24 pages

• Industries: Drug and Medication
• Countries: South Korea

Vaccine Sector in Bosnia and Herzegovina and South Korea

• Industry report
• January 2013
• 8 pages

... For h5n1 vaccines for risk groups Government to engage producer(s) into veterinary vaccine production Niche market for h5n1. Who-hhs meeting on business models, dc, jan 2013 5 ...

• Industries: Drug and Medication
• Countries: World, Bosnia and Herzegovina, South Korea

EDGAR Online Inc. - Company Report for Year 2012

• Company report
• November 2012
• 5 pages
• by Corporation

... As belviq or under a different trade name, we use belviq in this report to refer to the finished drug product for lorcaserin hydrochloride or, depending on the context, lorcaserin hydrochloride or other ...

• Industries: Drug and Medication
• Countries: South Korea, United States

Robert Lee - Company Report for Year 2012

• Company report
• November 2012
• 37 pages

... Companies are faced with many challenges such as drug price reductions and market share erosion by multinational companies. Nonetheless, we reiterate our overweight rating on the pharmaceutical sector ...

• Industries: Drug and Medication
• Countries: Japan, South Korea

Sigma-Aldrich Corp. - Company Report for Year 2012

• Company report
• October 2012
• 2 pages
• by Corporation

... Based crystalgenomics to support the development of active pharmaceutical ingredients (apis) for next-generation non- steroidal anti-inflammatory drugs (nsaid). The agreement represents safc's premier pre ...

• Industries: Drug and Medication
• Countries: South Korea

South Korea: Demographic Snapshot, August 2012

• Country report
• August 2012
• 3 pages

... Witnessed qualitative and quantitative growth stemming from population aging and increase in chronic diseases. However, the industry is likely to experience slowing growth as downward pressure on drug ...

• Industries: Drug and Medication
• Countries: South Korea

Vaccine Sector in South Korea, Japan and India

• Industry report
• July 2012
• 14 pages

... Total number of countries expected to co-finance and co-financing amount paid by countries* projected vaccine costs as a share of projected public spending on health, 2015 vaccines < 1 percent ...

• Industries: Drug and Medication
• Countries: South Korea, Japan, India

Medicine in South Korea and Malaysia : Innovation and Technology Trends

• Industry report
• July 2012
• 2 pages

... Metals, such as lead and mercury in herbal medicines. This kit relies on an advanced and highly- sensitive enzymatic assay. Business idea to design, develop, produce and distribute a commercial scale ...

• Industries: Drug and Medication
• Countries: South Korea, Malaysia, World

The South Korean Drug Market : Innovation and Technology Trends

• Industry report
• July 2012
• 6 pages

... To ice how does the interest between the government and the medical industry conflict Do you think that the nation S drug market suffers from over- competition resulting in the lack of profit ...

• Industries: Drug and Medication
• Countries: South Korea

Drug in South Korea : Innovation and Technology Trends

• Industry report
• June 2012
• 3 pages

... In government-led r&d projects tax support expand corporate income tax exemption related to r&d costs Proprietary technology: include phase i & ii clinical trials New growth engines: include vaccines ...

• Industries: Drug and Medication
• Countries: South Korea

Drug and Medication Market in Australia, South Korea and India

• Industry report
• April 2012
• 9 pages

... And consuming focus. We expect that by year S end we will have commenced our phase 3 trial for oxycodone, as well as establishing the international division of our personal care business, bioelixia . We ...

• Industries: Drug and Medication
• Countries: Australia, South Korea, India

Company Report: Drug in Japan and South Korea for Year 2012

• Company report
• March 2012
• 2 pages

... Filed 39 drug master files ________________________________ aiming to emerge as a global pharmaceuticals company by 2015 ________________________________ for more information: sameer madan vice ...

• Industries: Drug and Medication
• Countries: Japan, World, South Korea

Company Report: Drug in South Korea for Year 2012

• Company report
• March 2012
• 16 pages

... Modified drugs (imds) are original drugs that have been improved (in terms of safety and efficacy). There are a number of different imds such as isomer, combination, and new formulation. As r&d costs ...

• Industries: Drug and Medication
• Countries: South Korea

Drug and Medication Sector in South Korea and The United States

• Industry report
• March 2012
• 25 pages

... Sales was usd 2.5B and usd 30m sales in korea with double digit cagr (2010) Next generation nsaid such as cg100649 that can provide both high efficacy and low side effects, is likely to capture ...

• Industries: Drug and Medication
• Countries: South Korea, United States, World

Company Report: Drug and Medication in South Korea, The United States and Japan for Year 2012

• Company report
• March 2012
• 28 pages

... drug development the company has been striving to develop its own new drugs since 2000. As a result, several drugs have been fed in its pipeline. Cwp-231a, a targeted cancer drug inhibiting wnt ...

• Industries: Drug and Medication
• Countries: South Korea, United States, Japan

Company Report: Drug and Medication in Asia for Year 2012

• Company report
• March 2012
• 3 pages
• by Corporation

• Industries: Drug and Medication
• Countries: Singapore, South Korea, Asia

Company Report: Drug and Medication in South Korea and The United States for Year 2012

• Company report
• March 2012
• 38 pages

... Trajenta (Dpp-iv inhibitor: diabetes), Prevenar (Pneumococcal vaccine), Micardis (Arb hypertension drug), Viread (Hepatitis b treatment), and Pradaxa (Anticoagulant). The company targeted 2012 ...

• Industries: Drug and Medication
• Countries: South Korea, United States

Company Report: Drug and Medication in South Korea and The United States for Year 2012

• Company report
• February 2012
• 28 pages

... Source: company data, leading research center anti-cancer drug development the company has been striving to develop its own drugs since 2000. As a result, several drugs have been fed in its ...

• Industries: Drug and Medication
• Countries: South Korea, United States

Company Report: Vaccine in The United States, South Korea and China for Year 2011

• Company report
• November 2011
• 4 pages

... Development technology. Also, seasonable flu vaccine exports to the us are likely within 1h12. Maintain buy and target price of w210,000 We expect the company to post 2012 sales of w945.7Bn (up 23.2% Y ...

• Industries: Drug and Medication
• Countries: United States, South Korea, China

Company Report: Vaccine in The United States and South Korea for Year 2011

• Company report
• November 2011
• 5 pages

... Operating profit soared largely thanks to a decline in r&d expenses (down w6.4Bn yoy), as well as flu vaccine sales growth. However, as r&d expenses are likely to increase once again, the company s operating ...

• Industries: Drug and Medication
• Countries: United States, South Korea

Company Report: Drug and Medication in The United States and South Korea for Year 2011

• Company report
• November 2011
• 4 pages

... A w2.2Bn fine from the korean fair trade commission (ftc) for conspiring with gsk to influence the sales of certain drugs; and 3) a higher sales portion for merchandise imported from gsk and bayer ...

• Industries: Drug and Medication
• Countries: United States, South Korea

Company Report: Drug and Medication in South Korea and The United States for Year 2011

• Company report
• November 2011
• 6 pages

... Analysts who prepared this report are registered as research analysts in korea but not in any other jurisdiction, including the u.S. Sk chemicals (006120 ks) pharmaceutical new drug progress ...

• Industries: Drug and Medication
• Countries: South Korea, United States

Company Report: Drug and Medication in South Korea and The United States for Year 2011

• Company report
• November 2011
• 8 pages

... cancer drug 1st stage underway in the us and hong kong hm781-36b target cancer drug 2nd stage in korea anti-cancer drug hm61713 target cancer drug 1st stage in korea amozartan respiratory ...

• Industries: Drug and Medication
• Countries: South Korea, United States

Company Report: Drug and Medication in The United States and South Korea for Year 2011

• Company report
• October 2011
• 7 pages

... And expects to sign joint distribution deals in europe in early 2012. In addition, it is in drug price negotiations for Da-9701 (prokinetic agent), which will likely hit the korean market in dec 2011 ...

• Industries: Drug and Medication
• Countries: United States, South Korea

Company Report: Drug in South Korea and China for Year 2011

• Company report
• September 2011
• 2 pages

• Industries: Drug and Medication
• Countries: South Korea, China

Company Report: Drug and Medication in Japan, South Korea and India for Year 2011

• Company report
• July 2011
• 32 pages

... drugs have increased due to the patent cliff. Asian api makers to advance Asian api makers Strength is their high skill and low cost. We expect demand for asian apis to rise from us$8bn in 2010 ...

• Industries: Drug and Medication
• Countries: Japan, South Korea, India

Company Report: Vaccine in South Korea, The United States and China for Year 2011

• Company report
• July 2011
• 6 pages

... Early next year (sales of w13.0Bn estimated for 2013) and; 3) expected export growth for flu vaccine product Multi dose, As it should get who pq (pre-qualification) for use early next year. As all ...

• Industries: Drug and Medication
• Countries: South Korea, United States, China

Drug in South Korea : Innovation and Technology Trends

• Industry report
• July 2011
• 33 pages

• Industries: Drug and Medication
• Countries: South Korea

Company Report: Drug and Medication in Asia for Year 2011

• Company report
• June 2011
• 4 pages

• Industries: Drug and Medication
• Countries: India, South Korea, Asia

Company Report: Vaccine in The United States, South Korea and Philippines for Year 2011

• Company report
• May 2011
• 6 pages

... Fell 1%p q-q, as cogs ratio on blood derivatives, which account for the largest sales portion (35%), declined 5%p from 63% to 58%. R&d expense and flu vaccine price key to earnings R&d expense ...

• Industries: Drug and Medication
• Countries: United States, South Korea, Philippines